Effects of tetrandrine plus radiation on neuroblastoma cells

Anticancer Research

Volumn 29, Issue 8, 2009, Pages 3163-3171

  Chen, Yun ^a,b   Chen, Jin Cherng ^c   Tseng, Sheng Hong ^b,d  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b YUAN ZE UNIVERSITY   (Taiwan)

^c BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cytotoxicity; Neuroblastoma; Radiosensitization; Tetrandrine

Indexed keywords

BISBENZYLISOQUINOLINE ALKALOID; TETRANDRINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CONTROLLED STUDY; CYTOTOXICITY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROBLASTOMA CELL; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIZATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BENZYLISOQUINOLINES; CELL CYCLE; CELL DEATH; CESIUM RADIOISOTOPES; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUGS, CHINESE HERBAL; HUMANS; NEUROBLASTOMA; RADIATION-SENSITIZING AGENTS; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 68549109512     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Yoshida H, Enomoto H, Kawamura K et al: Antitumor vaccine effect of irradiated murine neuroblastoma cells producing interleukin-2 or granulocyte macrophage-colony stimulating factor. Int J Oncol 13: 73-78, 1998. (Pubitemid 28267497)
2. Davidoff AM, Kimbrough SA, Ng CY et al: Neuroblastoma regression and immunity induced by transgenic expression of interleukin-12. J Ped Surg 34: 902-907, 1999.
3. Graham-Pole J, Casper J, Elfenbein G et al: High-dose chemotherapy supported by marrow infusions for advanced neuroblastoma: a Pediatric Oncology Group Study. J Clin Oncol 9: 152-158, 1991.
4. Ho LJ, Chang DM, Lee TC et al: Plant alkaloid tetrandrine down-regulates protein kinase C-dependent signaling pathway in T-cells. Eur J Pharmacol 367: 389-398, 1999.
5. Jang BC, Lim KJ, Paik JH et al: Tetrandrine-induced apoptosis is mediated by activation of caspases and PKC-δ in U937 cells. Biochem Pharmacol 67: 1819-1829, 2004.
6. Park PH, Nan JX, Park EJ et al: Effect of tetrandrine on experimental hepatic fibrosis induced by bile duct ligation and scission in rats. Pharmacol Toxicol 87: 261-268, 2000.
7. Pang L and Hoult JRS: Cytotoxicity to macrophages of tetrandrine, an antisilicosis alkaloid, accompanied by an overproduction of prostaglandins. Biochem Pharmacol 53: 773-782, 1997. (Pubitemid 27145782)
8. Wang G, Lemos JR and Iadecola C: Herbal alkaloid tetrandrine: from an ion channel blocker to inhibitor of tumor proliferation. Trends Pharmacol Sci 25: 120-123, 2004. (Pubitemid 38264500)
9. Kondo Y, Takano F and Hojo H: Suppression of lipopolysaccharide-induced fulminant hepatitis and tumor necrosis factor production by bis- benzylisoquinoline alkaloids in bacillus Calmette-Guerin-treated mice. Biochem Pharmacol 46: 1861-1863, 1993.
10. Li SY, Teh BS, Seow WK et al: Effect of tetrandrine on immunological response and cardiac transplant rejection in mice. Int Arch Allergy Appl Immunol 90: 169-173, 1989.
11. Liu BC, He YX, Miao Q et al: The effect of tetrandrine and polyvinylpyridine-N-oxide (PVNO) on gene expression of type I and III collagens during experimental silicosis. Biomed Environ Sci 7: 199-204, 1994.
12. Xiao JG, Wu SY, Wang YL et al: Inhibitory effects of tetrandrine on bovine serum albumin-induced uveitis in rabbits. J Ocular Pharmacol 9: 151-156, 1993.
13. Lin TY, Tseng SH, Lin SJ et al: Tetrandrine increased the survival rate of mice with lipopolysaccharide-induced endotoxemia. J Trauma 66: 411-417, 2009.
14. Huang YT, Cheng YR, Lin HC et al: Haemodynamic effects of chronic tetrandrine treatment in portal hypertensive rats. J Gastroenterol Hepatol 12: 585-589, 1997. (Pubitemid 27364588)
15. Koh SB, Ban JY, Lee BY et al: Protective effects of fangchinoline and tetrandrine on hydrogen peroxide-induced oxidative neuronal cell damage in cultured rat cerebellar granule cells. Planta Med 69: 506-512, 2003.
16. Shen YC, Chen CF and Sung YJ: Tetrandrine ameliorates ischaemia-reperfusion injury of rat myocardium through inhibition of neutrophil priming and activation. Br J Pharmacol 128: 1593-1601, 1999.
17. Fu LW, Zhang YM, Liang YJ et al: The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells. Eur J Cancer 38: 418-426, 2002.
18. 2 cells. Life Sci 73: 243-252, 2003. (Pubitemid 36559604)
19. Lai YL, Chen YJ, Wu TY et al: Induction of apoptosis in human leukemic U937 cells by tetrandrine. Anti-Cancer Drugs 9: 77-81, 1998.
20. Lee JH, Kang GH, Soh Y et al: Tetrandrine induced cell cycle arrest and apoptosis in A549 human lung carcinoma cells. Int J Oncol 21: 1239-1244, 2002.
21. Kuroda H, Nakazawa S, Katagiri K et al: Antitumor effect of bisbenzylisoquinoline alkaloids. Chem Pharm Bull 24: 2413-2420, 1976.
22. Chen Y, Chen JC and Tseng SH: Tetrandrine suppresses tumor growth and angiogenesis of gliomas in rats. Int J Cancer 124: 2260-2269, 2009. (Pubitemid 38375581)
23. Chen M, Hough AM and Lawrence TS: The role of p53 in gemicitabine- mediated cytotoxicity and radiosensitization. Cancer Chemother Pharmacol 45: 369-374, 2000. (Pubitemid 30217160)
24. Chen Y, Lin TY, Chen JC et al: GL331 (a topoisomerase II inhibitor) induces radiosensitization of human glioma cells. Anticancer Res 26: 2149-2156, 2006. (Pubitemid 43989483)
25. Chang KH, Chen ML, Chen HC et al: Enhancement of radiosensitivity in human glioblastoma U138MG cells by tetrandrine. Neoplasma 46: 196-200, 1999.
26. Sun X, Xu R, Deng Y et al: effects of tetrandrine on apoptosis and radiosensitivity of nasopharyngeal carcinoma cell line CNE. Acta Biochem Biophy Sinica 39: 869-878, 2007. (Pubitemid 350136894)
27. Jin Q, Kang C, Soh Y et al: Tetrandrine cytotoxicity and its dual effect on oxidative stress-induced apoptosis through modulating cellular redox states in Neuro 2a mouse neuroblastoma cells. Life Sci 71: 2053-2066, 2002. (Pubitemid 34908009)
28. Steel GG and Peckham MJ: Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Rad Oncol Biol Phys 5: 85-91, 1979.
29. Giocanti N, Hennequin C, Balosso J et al: DNA repair and cell cycle interactions in radiation sensitization by the topoisomerase II poison etoposide. Cancer Res 53: 2105-2111, 1993. (Pubitemid 23145734)
30. Song Q, Baxter GD, Kovacs EM et al: Inhibition of apoptosis in human tumour cells by okadaic acid. J Cell Physiol 153: 550-556, 1992.
31. Matthay KK, Villablanca JG, Seeger RC et al: Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cii-retinoic acid. Children's Cancer Group. N Engl J Med 341: 1165-1173, 1999.
32. Xie X, Sasai K, Shibuya K et al: P53 status plays no role in radiosensitizing effects of SN-38, a camptothecin derivative. Cancer Chemother Pharmacol 45: 362-368, 2000. (Pubitemid 30217159)
33. + channel-mediated tumor cell proliferation and apoptosis. Apoptosis 12: 1837-1846, 2007.
34. Cip1. Cancer Res 64: 9086-9092, 2004. (Pubitemid 39665522)
35. 2/M delay and cellular radiosensitivity. Int J Radiat Biol 66: 373-379, 1994. (Pubitemid 2143397)
36. O'Connor PM and Kohn KW: A fundamental role for cell cycle regulation in the chemosensitivity of cancer cells? Semin Cancer Biol 3: 409-416, 1992.
37. Bases R, Mendez F and Franklin WA: Enhanced repair endonuclease activities from radiation-arrested G(2) phase mammalian cells. Int J Radiat Biol 65: 591-603, 1994. (Pubitemid 24167411)
38. 2 delay potentiates cell death by apoptosis and/or the induction of giant cells in colorectal tumor cells with disrupted p53 function. Clin Cancer Res 3: 1371-1381, 1997.
39. 2 checkpoint inhibitor. Clin Cancer Res 2: 791-797, 1996.
40. Su L and Little JB: Prolonged cell cycle delay in radioresistant human cell lines transfected with activated ras oncogene and/or Simian virus 40 T-antigen. Radiat Res 133: 73-79, 1993. (Pubitemid 23070028)
41. Chen AY, Okunieff P, Pommier Y et al: Mammalian DNA topoisomerase I mediates the enhancement of radiation cytotoxicity by camptothecin derivatives. Cancer Res 57: 1529-1536, 1997. (Pubitemid 27175571)